Ye et al. [13] and Yang et al. [14] reported significant correlations between IRAK1 expression and tumor size in hepatocellular carcinoma tissues and during neoadjuvant chemotherapy of breast cancer. Here, IRAK1 is linked to hepatocellular carcinoma.